Jonathan JD - Adapthealth Corp General Counsel
| AHCO Stock | USD 9.58 0.46 4.58% |
Executive
Jonathan JD is General Counsel of Adapthealth Corp
| Age | 55 |
| Address | 220 West Germantown Pike, Plymouth Meeting, PA, United States, 19462 |
| Phone | 610 424 4515 |
| Web | https://adapthealth.com |
Adapthealth Corp Management Efficiency
The company has return on total asset (ROA) of 0.0411 % which means that it generated a profit of $0.0411 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1288) %, meaning that it created substantial loss on money invested by shareholders. Adapthealth Corp's management efficiency ratios could be used to measure how well Adapthealth Corp manages its routine affairs as well as how well it operates its assets and liabilities. As of the 4th of December 2024, Return On Tangible Assets is likely to grow to -0.39. In addition to that, Return On Capital Employed is likely to grow to -0.14. At this time, Adapthealth Corp's Non Currrent Assets Other are very stable compared to the past year. As of the 4th of December 2024, Other Assets is likely to grow to about 362.8 M, while Total Assets are likely to drop about 2.7 B.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Sarah Huber | Pulmonx Corp | N/A | |
| Suzanne Armstrong | Orthofix Medical | N/A | |
| Scott Galovan | Avanos Medical | N/A | |
| Jeff Sears | Paragon 28 | N/A | |
| Marshall MD | Artivion | 67 | |
| Dylan John | Neuropace | N/A | |
| Matthew Millard | Paragon 28 | N/A | |
| Robert Thomson | Artivion | 54 | |
| Daniel JD | Orthopediatrics Corp | 54 | |
| Matthew Brinckman | Paragon 28 | N/A | |
| Kelley Nicholas | Neuropace | N/A | |
| Deanna Wilke | LivaNova PLC | N/A | |
| Yuliya Aslan | Paragon 28 | N/A | |
| Mark Namaroff | Anika Therapeutics | 61 | |
| Julie Andrews | Orthofix Medical | 53 | |
| Jill Mason | Orthofix Medical | N/A | |
| Stephen JD | Sight Sciences | N/A | |
| Tom Huang | Sight Sciences | N/A | |
| Jrme Erath | Pulmonx Corp | N/A | |
| Lisa Funiciello | Anika Therapeutics | N/A | |
| Bradley Nagel | Electromed | 42 | |
Management Performance
| Return On Equity | -0.13 | ||||
| Return On Asset | 0.0411 |
Adapthealth Corp Leadership Team
Elected by the shareholders, the Adapthealth Corp's board of directors comprises two types of representatives: Adapthealth Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Adapthealth. The board's role is to monitor Adapthealth Corp's management team and ensure that shareholders' interests are well served. Adapthealth Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Adapthealth Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jonathan JD, General Counsel | ||
| Nalin Narayanam, Chief Officer | ||
| Briah Carey, President Diabetes | ||
| Richard Barasch, Chairman CEO | ||
| Joel Mills, Chief Officer | ||
| Suzanne Foster, Chief Director | ||
| Wendy Russalesi, Chief Officer | ||
| Anton Hie, Vice Relations | ||
| Leila Vargas, Executive Marketing | ||
| Shaw Rietkerk, Chief Officer | ||
| Albert Prast, Chief Officer | ||
| Scott Barnhart, Chief Officer | ||
| Jason CFA, Chief Officer | ||
| Stephen Griggs, CEO Director | ||
| Christopher Joyce, Secretary | ||
| Joshua Parnes, President Director | ||
| Christie Archbold, Chief Officer | ||
| Daniel Bunting, Chief Operations | ||
| Jonathan Bush, General Counsel |
Adapthealth Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Adapthealth Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.13 | ||||
| Return On Asset | 0.0411 | ||||
| Profit Margin | (0.07) % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | 3.43 B | ||||
| Shares Outstanding | 134.56 M | ||||
| Shares Owned By Insiders | 11.92 % | ||||
| Shares Owned By Institutions | 94.92 % | ||||
| Number Of Shares Shorted | 9.96 M | ||||
| Price To Earning | 25.41 X |
Pair Trading with Adapthealth Corp
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Adapthealth Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adapthealth Corp will appreciate offsetting losses from the drop in the long position's value.Moving against Adapthealth Stock
| 0.71 | MD | Mednax Inc | PairCorr |
| 0.71 | ELMD | Electromed | PairCorr |
| 0.63 | VREX | Varex Imaging Corp | PairCorr |
| 0.63 | ECOR | Electrocore LLC | PairCorr |
| 0.59 | OM | Outset Medical Buyout Trend | PairCorr |
The ability to find closely correlated positions to Adapthealth Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Adapthealth Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Adapthealth Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Adapthealth Corp to buy it.
The correlation of Adapthealth Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Adapthealth Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Adapthealth Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Adapthealth Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adapthealth Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Adapthealth Stock, please use our How to Invest in Adapthealth Corp guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adapthealth Corp. If investors know Adapthealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adapthealth Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.444 | Earnings Share (1.67) | Revenue Per Share 24.465 | Quarterly Revenue Growth 0.002 | Return On Assets 0.0411 |
The market value of Adapthealth Corp is measured differently than its book value, which is the value of Adapthealth that is recorded on the company's balance sheet. Investors also form their own opinion of Adapthealth Corp's value that differs from its market value or its book value, called intrinsic value, which is Adapthealth Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adapthealth Corp's market value can be influenced by many factors that don't directly affect Adapthealth Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adapthealth Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Adapthealth Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adapthealth Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.